Literature DB >> 11221439

State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey.

R S DiPaola1, P Kumar, W N Hait, R E Weiss.   

Abstract

Prostate cancer is a devastating disease that will be diagnosed in approximately 200,000 men in 2001. New methods for screening, prevention, and treatment are being developed. In addition, novel agents for the treatment of resistant prostate cancer are being developed in clinical trials. This review summarizes the recent efforts in diet, screening, novel systemic therapies, and alternative medicine for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11221439

Source DB:  PubMed          Journal:  N J Med        ISSN: 0885-842X


  1 in total

1.  Characterization of human ribosomal S3a gene expression during adenosine 3':5' cyclic monophosphate induced neuroendocrine differentiation of LNCaP cells. Regulation of S3a gene expression in LNCaP.

Authors:  Jeremy L Goodin; Charles L Rutherford
Journal:  Mol Biol Rep       Date:  2002-09       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.